A paragonimiasis patient with allergic reaction to praziquantel and resistance to triclabendazole: successful treatment after desensitization to praziquantel

Korean J Parasitol. 2011 Mar;49(1):73-7. doi: 10.3347/kjp.2011.49.1.73. Epub 2011 Mar 18.

Abstract

Paragonimiasis is an infectious disease caused by trematodes of the genus Paragonimus. This trematode can be treated successfully with praziquantel in more than 90% of the cases. Although praziquantel is generally well tolerated, anaphylactic reactions to this drug have been reported in a few cases. We report here a 46-year-old Korean female with paragonimiasis, presumed to be due to Paragonimus westermani, who displayed an allergic reaction to praziquantel and resistance to triclabendazole treatment. The patient was successfully treated with praziquantel following a rapid desensitization procedure. Desensitization to praziquantel could be considered when no alternative drugs are available.

Keywords: Paragonimus; desensitization; drug allergy; paragonimiasis; praziquantel; triclabendazole.

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Benzimidazoles / therapeutic use*
  • Desensitization, Immunologic*
  • Drug Hypersensitivity / etiology
  • Drug Hypersensitivity / immunology
  • Drug Hypersensitivity / therapy*
  • Drug Resistance*
  • Female
  • Humans
  • Middle Aged
  • Paragonimiasis / drug therapy*
  • Paragonimiasis / immunology
  • Paragonimiasis / parasitology
  • Paragonimus / isolation & purification
  • Paragonimus / physiology
  • Praziquantel / adverse effects*
  • Praziquantel / immunology*
  • Praziquantel / therapeutic use
  • Treatment Outcome
  • Triclabendazole

Substances

  • Benzimidazoles
  • Triclabendazole
  • Praziquantel